Journal Mobile Options
Table of Contents
Vol. 56, No. 3, 1999
Issue release date: April 1999
Oncology 1999;56:189–192

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

Stroffolini T. · Andreone P. · Andriulli A. · Ascione A. · Craxì A. · Chiaramonte M. · Galante D. · Manghisi O.G. · Mazzanti R. · Medaglia C. · Pilleri G. · Rapaccini G.L. · Albanese M. · Taliani G. · Tosti M.E. · Villa E. · Gasbarrini G.
aLaboratorio di Epidemiologia, ISS, Roma, bIstituto di Patologia Medica, University of Bologna, cDepartment of Gastroenterology, IRCCS. S. Giov. Rotondo Hospital, Sangiovanni Rotondo, dDepartment of Gastroenterology, Cardarelli Hospital Napoli, eIstituto di Medicina Interna, University of Palermo, fDivisione Gastroenterologia, University of Padova, gClinica Malattie Infettive, University of Napoli, hDepartment of Gastroenterology, Castellana Grotte Hospital, Castellana Grotte, iIstituto di Clinica Medica, University of Firenze, jIstituto di Medicina Interna, IRCCS Maggiore Hospital, Milano, kDepartment of Internal Medicine, Cagliari Hospital, Cagliari, lClinica Medica, Policlinico Gemelli, University of Rome, mClinica Medica R, University of Palermo, nClinica Malattie Tropicali, University of Rome, and oDivisione Gastroenterologia, University of Modena, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The prevalence and independent predictors of the different macroscopic types of hepatocellular carcinoma (HCC) were assessed in 1,073 unselected patients of 14 hospitals in Italy from May 1996 to May 1997. Solitary HCC was the most common cancer type (44.6%), followed by multinodular (44.2%), diffuse (8.4%) and massive (2.8%) types. After adjustment for the influence of confounders by multiple logistic regression analysis, Child-Pugh grades B and C were found to be independent predictors of multinodular (odds ratio, OR, 2.0; 95% confidence interval (CI) = 1.5–2.6) and diffuse (OR 2.6; 95% CI = 1.6–4.4) HCC types. These findings indicate that the majority of HCC cases are not detected at a potentially treatable stage. Delayed detection of HCC is associated with a higher likelihood of the multinodular or diffuse gross pathologic type.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Okuda K, Peters RL, Simson IW: Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Cancer 1984;54:2165–2173.

    External Resources

  2. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S: Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study of 22 patients. Gastroenterology 1986;90:289–298.
  3. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680–687.
  4. Ohto M, Ebara M, Sugiura N, Yoshikawa M: Present trends in Japan with regard to epidemiology and clinical features of hepatocellular carcinoma. Ital J Gastroenterol 1992;24:144–145.
  5. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, Virdone R, Fusco G, Grasso R, Simonetti RG, Pagliaro L: Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: An 8 year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994;21:1029–1034.
  6. Pugh RNH, Murray Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–649.
  7. Ohto M, Ebara M, Okuda K: Ultrasonography in the diagnosis of hepatic tumour; in Okuda K, Ishak KG (eds): Neoplasms of the Liver. Tokyo, Springer, 1987, pp 251–258.
  8. Eggel A: Über das primäre Carcinoma der Leber. Beitr Pathol Anat 1901;30:506–604.
  9. Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y: Growth and spread of hepatocellular carcinoma: A review of 24 consecutive autopsy cases. Cancer 1990;66:2174–2179.
  10. Klein Baum DG, Kuppler LL, Chambless LE: Logistic regression analysis of epidemiological data. Theory and practice. Commun Statist Theory Methods 1982;71:485–547.
  11. Colombo M: Hepatocellular carcinoma. J Hepatol 1992;15:225–236.
  12. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tomassini MA, Donato MF, Piva A, Di Carlo V, Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675–680.
  13. Trevisani F, Caraceni P, Bernandi M, D’Intino PE, Arienti V, Amorati P: Gross pathologic types of hepatocellular carcinoma in Italian patients. Cancer 1993;72:1557–1563.
  14. Pateron D, Ganne N, Trinchet JC, Aurosseau H, Mal F, Meicler C: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65–70.
  15. Miyagawa S, Kawasaki S, Makuuchi M: Comparison of the characteristics of hepatocellular carcinoma between hapatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307–310.
  16. Ricca Rossellini S, Arienti V, Nanni O, Ugenti F, Tassinari M, Camporesi C: Hepatocellular carcinoma: Prognostic factors and survival analysis of 135 Italian patients. J Hepatol 1992;16:66–72.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50